489 related articles for article (PubMed ID: 26304481)
1. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
[TBL] [Abstract][Full Text] [Related]
2. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
[TBL] [Abstract][Full Text] [Related]
3. Short- to mid-term results using autologous bone-marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
Franz RW; Shah KJ; Johnson JD; Pin RH; Parks AM; Hankins T; Hartman JF; Wright ML
Vasc Endovascular Surg; 2011 Jul; 45(5):398-406. PubMed ID: 21669864
[TBL] [Abstract][Full Text] [Related]
4. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
Gabr H; Hedayet A; Imam U; Nasser M
Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
[TBL] [Abstract][Full Text] [Related]
6. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization.
Malgor RD; Ricotta JJ; Bower TC; Oderich GS; Kalra M; Duncan AA; Gloviczki P
Ann Vasc Surg; 2012 Oct; 26(7):946-56. PubMed ID: 22944568
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
Van Tongeren RB; Hamming JF; Fibbe WE; Van Weel V; Frerichs SJ; Stiggelbout AM; Van Bockel JH; Lindeman JH
J Cardiovasc Surg (Torino); 2008 Feb; 49(1):51-8. PubMed ID: 18212687
[TBL] [Abstract][Full Text] [Related]
9. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
Rigato M; Monami M; Fadini GP
Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
van Haelst STW; Teraa M; Moll FL; de Borst GJ; Verhaar MC; Conte MS
J Vasc Surg; 2018 Oct; 68(4):1104-1113.e1. PubMed ID: 29802042
[TBL] [Abstract][Full Text] [Related]
11. Endovascular recanalization of native chronic total occlusions in patients with failed lower-extremity bypass grafts.
Wrigley CW; Vance A; Niesen T; Grilli C; Velez JD; Agriantonis DJ; Kimbiris G; Garcia MJ; Leung DA
J Vasc Interv Radiol; 2014 Sep; 25(9):1353-9. PubMed ID: 25060042
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of lower extremity revascularization among the hemodialysis-dependent.
Fallon JM; Goodney PP; Stone DH; Patel VI; Nolan BW; Kalish JA; Zhao Y; Hamdan AD;
J Vasc Surg; 2015 Nov; 62(5):1183-91.e1. PubMed ID: 26254454
[TBL] [Abstract][Full Text] [Related]
13. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.
Darling JD; McCallum JC; Soden PA; Meng Y; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
J Vasc Surg; 2016 Sep; 64(3):616-22. PubMed ID: 27380993
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
[TBL] [Abstract][Full Text] [Related]
15. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.
Robinson WP; Loretz L; Hanesian C; Flahive J; Bostrom J; Lunig N; Schanzer A; Messina L
J Vasc Surg; 2017 Aug; 66(2):488-498.e2. PubMed ID: 28410924
[TBL] [Abstract][Full Text] [Related]
16. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
[TBL] [Abstract][Full Text] [Related]
17. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
19. Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.
Chiriano J; Bianchi C; Teruya TH; Mills B; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2010 Nov; 24(8):1110-6. PubMed ID: 21035703
[TBL] [Abstract][Full Text] [Related]
20. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
